T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Brookfield Renewable
BEP
$10.6B
| $13.1M | ﹤0.01% |
527,229
-644,219
| -55% | -$16M |
|
1052
Astera Labs
ALAB
$56B
| $13M | ﹤0.01% |
214,486
-385,514
| -64% | -$26.7M |
|
1053
Hormel Foods
HRL
$13.4B
| $12.9M | ﹤0.01% |
422,570
+18,125
| +4% | +$610K |
|
1054
Fortune Brands Innovations
FBIN
$5.78B
| $12.8M | ﹤0.01% |
197,511
-6,119
| -3% | -$442K |
|
1055
WEX
WEX
$6.78B
| $12.8M | ﹤0.01% |
72,238
-16,887
| -19% | -$3.44M |
|
1056
Henry Schein
HSIC
$10B
| $12.8M | ﹤0.01% |
198,896
+3,055
| +2% | +$215K |
|
1057
Ardelyx
ARDX
$1.01B
| $12.7M | ﹤0.01% |
1,719,071
-2,194,792
| -56% | -$15.4M |
|
1058
American Financial Group
AFG
$12.1B
| $12.7M | ﹤0.01% |
103,348
-27,189
| -21% | -$3.5M |
|
1059
nVent Electric
NVT
$27.5B
| $12.7M | ﹤0.01% |
165,825
+65,441
| +65% | +$5.08M |
|
1060
United Parks & Resorts
PRKS
$2.04B
| $12.7M | ﹤0.01% |
233,227
+3,050
| +1% | +$159K |
|
1061
US Foods
USFD
$23.8B
| $12.6M | ﹤0.01% |
237,634
+75,506
| +47% | +$3.97M |
|
1062
CONMED
CNMD
$1.49B
| $12.5M | ﹤0.01% |
181,010
-14,624
| -7% | -$1.07M |
|
1063
Ibotta
IBTA
$769M
| $12.5M | ﹤0.01% |
+166,825
| New | +$15.5M |
|
1064
Boston Properties
BXP
$11B
| $12.4M | ﹤0.01% |
201,897
+6,344
| +3% | +$388K |
|
1065
Bio-Rad Laboratories Class A
BIO
$9.66B
| $12.4M | ﹤0.01% |
45,350
+768
| +2% | +$223K |
|
1066
Belden
BDC
$5.36B
| $12.4M | ﹤0.01% |
131,923
-1,546
| -1% | -$141K |
|
1067
Campbell Soup
CPB
$6.94B
| $12.2M | ﹤0.01% |
269,279
+3,099
| +1% | +$138K |
|
|
WBA
1068
DELISTED
Walgreens Boots Alliance
WBA
| $12.2M | ﹤0.01% |
1,005,532
+31,895
| +3% | +$541K |
|
1069
Flywire
FLYW
$2.22B
| $12.1M | ﹤0.01% |
739,568
+7,981
| +1% | +$151K |
|
1070
DaVita
DVA
$11.4B
| $12.1M | ﹤0.01% |
87,230
+1,944
| +2% | +$268K |
|
1071
BioCryst Pharmaceuticals
BCRX
$2.51B
| $12M | ﹤0.01% |
1,948,984
+1,818,209
| +1,390% | +$10M |
|
1072
BWX Technologies
BWXT
$15.6B
| $12M | ﹤0.01% |
126,048
-22,707
| -15% | -$2.11M |
|
1073
Affiliated Managers Group
AMG
$9.7B
| $11.9M | ﹤0.01% |
76,380
+6,461
| +9% | +$1.03M |
|
1074
Pinnacle West Capital
PNW
$12.2B
| $11.8M | ﹤0.01% |
155,029
+4,731
| +3% | +$357K |
|
1075
Caesars Entertainment
CZR
$6.04B
| $11.8M | ﹤0.01% |
296,975
+7,660
| +3% | +$288K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.